CD30-Specific CAR T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma
Natalie S. Grover, MD, discusses the potential role of CD30-specific chimeric antigen receptor T cells in patients with relapsed/refractory Hodgkin Lymphoma.